doctitl opportun licens neutral monoclon antibodi respiratori syncyti viru doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari nation institut health nih depart health human servic dhh seek license effect pursu preclin clinic commerci develop human monoclon antibodi respiratori syncyti viru rsv nih intend grant select firm world wide royalti bear licens practic invent embodi u patent applic sn 07 945 515 entitl human neutral monoclon antibodi respiratori syncyti viru relat foreign patent applic avail field use patent right invent jointli assign unit state america scripp research institut summari supplem supplementari inform nih seek license accord requir regul govern licens govern own invent 37 cfr part 404 meritori plan develop rsv monoclon antibodi treatment prevent rsv infect market statu meet need public best term nih criteria nih use evalu licens applic includ limit set forth 37 cfr 404 7 1 ii iv supplem date date view high prioriti develop prophylact treatment rsv infect propos must receiv juli 27 1994 date address address request copi patent applic licens applic form question comment concern licens technolog direct mark hankin esq technolog licens specialist offic technolog transfer nation institut health 6011 execut boulevard suit 325 rockvil md 208523804 telephon 301 4967735 ext 265 facsimil 301 4020220 sign confidenti agreement requir receiv copi patent applic date june 15 1994 address signer barbara mcgarey j signer signjob deputi director offic technolog transfer signjob frfile fr doc 9415470 file 62494 8 45 frfile bill bill code 414001p bill